The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS).
The main questions it aims to answer are:
* is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results? * is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease?
Participants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.
Age over 18
suspect of soft tissue sarcoma with a indication for surgical treatment
suspect of bone cancer tumor with a indication for surgical treatment
To give informed consent
simultaneous cancer or history of cancer in the last 5 years
acute or chronic serious conditions that could
renal failure without dialysis
history of allergy to a paramagnetic contrast agent
The study population consists in participants with a suspect of soft tissue sarcoma or bone cancer that are followed at Radiology Department of IRCCS Azienda Ospedaliero-Universitaria hospital in the city of Bologna.
Cohort
Prospective
Not listed
Positive Predictive Value (PPV)
It is the ratio of patients truly diagnosed as positive to all those who had positive test results (including healthy subjects who were incorrectly diagnosed as patient).
Negative Predictive Value (NPV)
It is the ratio of subjects truly diagnosed as negative to all those who had negative test results (including patients who were incorrectly diagnosed as healthy).
Click on the lead sponsor to view all of their trials.
